Literature DB >> 13587851

Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

R C SKARNES, F S ROSEN, M J SHEAR, M LANDY.   

Abstract

A humoral substance which inactivates endotoxin in vitro has been shown to be clearly distinguishable from complement, properdin, and specific antibody. For the present, it is designated "endotoxin-detoxifying component" or EDC. Animal species could be grouped in three categories with regard to the EDC activity of their sera; rat serum was highly potent; chimpanzee, dog, horse, and guinea pig sera were much less active; mouse, rabbit, and sheep sera exhibited no activity. The EDC potency of human sera varied widely, ranging from high to barely discernible activity. In contrast to the variations of EDC potency in serum, citrated plasma from all species manifested high potency of about the same magnitude. The influence of time, temperature, pH, and concentration of reactants on the inactivation of endotoxin by EDC was examined. EDC activity in plasma and serum was found to be labile to beating at 56 degrees C. for 1 hour. Bacterial endotoxins, derived by different isolation procedures from smooth and rough Gram-negative species, varied considerably in susceptibility to EDC action.

Entities:  

Keywords:  BACTERIA; BLOOD

Mesh:

Substances:

Year:  1958        PMID: 13587851      PMCID: PMC2136910          DOI: 10.1084/jem.108.5.685

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Bacterial pyrogens.

Authors:  I L BENNETT; L E CLUFF
Journal:  Pharmacol Rev       Date:  1957-12       Impact factor: 25.468

2.  Protective effect of components of normal blood against the lethal action of endotoxin.

Authors:  M HO; E H KASS
Journal:  J Lab Clin Med       Date:  1958-02

3.  Inactivation of biologically active endotoxic polysaccharides by fresh human serum.

Authors:  M LANDY; R C SKARNES; F S ROSEN; R J TRAPANI; M J SHEAR
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

4.  Inactivation of a bacterial pyrogen by human serum and plasma.

Authors:  W I CRANSTON; F GOODALE; E S SNELL; F WENDT
Journal:  Clin Sci       Date:  1956-11       Impact factor: 6.124

5.  Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Authors:  I H LEPOW; L WURZ; O D RATNOFF; L PILLEMER
Journal:  J Immunol       Date:  1954-09       Impact factor: 5.422

6.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

7.  The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system.

Authors:  D BOEHME; R J DUBOS
Journal:  J Exp Med       Date:  1958-04-01       Impact factor: 14.307

8.  Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

9.  Similarity of host responses elicited by polysaccharides of animal and plant origin and by bacterial endotoxins.

Authors:  M LANDY; M J SHEAR
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

10.  A study of the effect of serum on the immunological reaction of a bacterial endotoxin.

Authors:  L E CLUFF
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

View more
  30 in total

1.  THE INFLUENCE OF BACTERIOCINS ON RESISTANCE TO INFECTION BY GRAM-NEGATIVE BACTERIA. I. THE EFFECT OF COLICIN ON BACTERICIDAL POWER OF BLOOD.

Authors:  A I BRAUDE; J S SIEMIENSKI
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  Inactivation of endotoxin by a humoral component. VII. Enzymatic degradation of endotoxin by blood plasma.

Authors:  W R KEENE; M LANDY; M J SHEAR
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

3.  Inactivation of endotoxin by a humoral component. VI. Two separate systems required for viable and killed Salmonella typhosa.

Authors:  M LANDY; R J TRAPANI; F S ROSEN
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

Review 4.  Molecular aspects of endotoxic reactions.

Authors:  A Nowotny
Journal:  Bacteriol Rev       Date:  1969-03

5.  In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity.

Authors:  R C Skarnes
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

Review 6.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

7.  Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.

Authors:  H W Harris; C Grunfeld; K R Feingold; J H Rapp
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.

Authors:  P Brandtzaeg; K Bryn; P Kierulf; R Ovstebø; E Namork; B Aase; E Jantzen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate.

Authors:  T J Novitsky; P F Roslansky; G R Siber; H S Warren
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

10.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.